4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-21-003474
Options or other derivatives
- Chief Operating Officer acquired 134,376 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stuart Bryan Chief Operating Officer | 2021-01-25 | Grant or award · Stock Option (right to buy) | +134,376 | 134,376 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…